Bangladesh vs Honduras: The number of people with susceptibility test result for rifampicin
Bangladesh
43.54
in 2021
Honduras
42.38
in 2021
Bangladesh rank
121st
Honduras rank
123rd
The number of people with susceptibility test result for rifampicin over time
- Bangladesh
- Honduras
How they compare
Bangladesh currently reports 43.54 against 42.38 in Honduras, a difference of 1.16.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Honduras ahead.
Bangladesh ranks 121st and Honduras ranks 123rd of 146 countries.
Honduras has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Honduras | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 26.1 | 44.47 | 18.37 | Honduras |
| 2020s | 39.25 | 50.77 | 11.51 | Honduras |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bangladesh or Honduras?
- Bangladesh, at 43.54 against 42.38 in Honduras as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bangladesh and Honduras?
- 1.16, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Honduras?
- 5 years are reported by both, from 2017 to 2021.
- How do Bangladesh and Honduras rank globally for the number of people with susceptibility test result for rifampicin?
- Bangladesh ranks 121st and Honduras ranks 123rd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.